GL Communications Enhances Telecommunications and IT Consulting Services
May 20, 2024 11:55 ET
|
GL Communications, Inc.
GL Communications Inc. offers telecom and IT consulting services and test solutions for telecom, aerospace, defense, e-commerce, and healthcare industries.
Nature Medicine Highlights Significant Improvement in Hand and Arm Function After Spinal Cord Injury with Use of ONWARD® ARC-EX® Therapy
May 20, 2024 11:35 ET
|
ONWARD Medical NV
Nature Medicine Highlights Significant Improvement in Hand and Arm Function After Spinal Cord Injury with Use of ONWARD® ARC-EX® Therapy
NBME Senior Vice President Honored with 2024 OnCon Icon Award
May 20, 2024 10:19 ET
|
NBME
PHILADELPHIA, May 20, 2024 (GLOBE NEWSWIRE) -- NBME Senior Vice President, General Counsel and Chief Diversity, Equity and Inclusion (DEI) Officer Linda Gadsby, Esq. has been awarded the OnCon Icon...
WellSpan Health hosts more than 300 students and caregivers for Black Men in White Coats Youth Summit
May 20, 2024 09:50 ET
|
WellSpan Health
York, Pa., May 20, 2024 (GLOBE NEWSWIRE) -- Area students engaged in a full day of career exploration and networking this weekend as WellSpan Health partnered with York College to host the 2nd...
Briggs & Riley and Comfort Cases Proudly Celebrate the Ongoing Success of Giving Back to Youth in Foster Care
May 20, 2024 09:07 ET
|
Comfort Cases
The 2nd annual “Buy a Bag, Give a Bag” promotion with Brigs & Riley generated 58% more bag donations to Comfort Cases.
LIXTE Biotechnology Holdings Provides Update on Recent Activities
May 20, 2024 08:30 ET
|
Lixte Biotechnology Holdings, Inc.
Publishing of Findings in Recent Pre-Clinical Study for LIXTE’s Proprietary Compound, LB-100, in New Field of Cancer Biology, “Activation Lethality”Presentation at MedInvest Biotech and Pharma...
NKGen Biotech’s SNK01 NK Cell Therapy Cleared to Start Phase 2 Clinical Trial in Alzheimer’s Disease
May 20, 2024 08:05 ET
|
NKGen Biotech, Inc.
SNK01, a cryopreserved, autologous enhanced natural killer cell therapy, delivered in highest dose to date, demonstrates preliminary clinical benefit without any drug-related adverse events. Company...
CervoMed to Appoint William Elder as Chief Financial Officer
May 20, 2024 08:00 ET
|
CervoMed Inc.
BOSTON, May 20, 2024 (GLOBE NEWSWIRE) -- CervoMed Inc. (NASDAQ: CRVO), a clinical stage company focused on developing treatments for age-related neurologic disorders, today announced the appointment...
Biora Therapeutics Presents Clinical Data on Device Function of the NaviCap™ Platform at Digestive Disease Week 2024
May 20, 2024 08:00 ET
|
Biora Therapeutics, Inc.
Four device performance studies demonstrate the NaviCap platform’s ability to deliver therapeutics directly to the colon under variable GI conditions.
Candel Therapeutics to Host Non-Small Cell Lung Cancer (NSCLC) R&D Breakfast Panel During 2024 ASCO Annual Meeting
May 20, 2024 08:00 ET
|
Candel Therapeutics
NEEDHAM, Mass., May 20, 2024 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical stage biopharmaceutical company focused on developing multimodal...